Nancy C. Andrews serves as Executive at CHARLES RIVER LABORATORIES INTERNATIONAL, INC., where they oversee executive responsibilities. Since joining the company, Nancy C. Andrews has executed 6 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 13, 2024 involved receiving (via award) 559 shares valued at $127.7K.
Nancy C. Andrews currently holds 3,018 shares of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nancy C. Andrews has been a net neutral trader of CRL stock. They have purchased $0 and sold $0 worth of shares.
Nancy C. Andrews's most recent insider trade was on May 13, 2024, when they sold 559 shares at $228.41 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 11, 2022 | CRL | $0 | Award | 575 | $N/A | Discretionary |
| May 7, 2021 | CRL | $0 | Award | 355 | $N/A | Discretionary |
| May 11, 2020 | CRL | $0 | Award | 741 | $N/A | Discretionary |
| Mar 2, 2020 | CRL | $0 | Award | 124 | $N/A | Discretionary |